Option chain shows key data for Minor International's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Minor International.

Minor International (OTC:MIPCF) Stock, Option Chain

Minor International PCL operates hotels, restaurants, and several smaller businesses. The company operates in four segments: Hotel, with properties in Europe, Thailand, and Latin America; Restaurant, with locations primarily in Thailand, China, and Australia; Retail, which offers a wide range of high-end clothing and consumer products through stores and e-commerce in Thailand; and Mixed-Use. Most of its revenue comes from European hotels. A sizable portion of sales also comes from the restaurant segment in Thailand.

MINOR INTL PUB CO LTD by Minor International Public Co., Ltd.

Minor International PCL

Blaize announced the following financial guidance: revenue of $19 million to $50 million for fiscal year 2025 and revenue of $105 million to $140 million for fiscal year 2026, as solutions start to get deployed. Revenue from software and solutions is expected to comprise 15% to 25% of revenue in fiscal year 2025, increasing to between 20% to 30% of revenue in fiscal year 2026. Non-GAAP gross margins for fiscal years 2025 and 2026 are projected at approximately 46% to 50%. Non-GAAP research and development expense for fiscal year 2025 is expected to be approximately $49 million to $52 million, of which $18 million to $20 million is expected to be for third-party costs incurred for next-generation chips, and non-GAAP research and development expense for fiscal year 2026 is expected to be approximately $85 million to $89 million, of which $48 million to $52 million is expected to be for third-party costs incurred for next-generation chips. Non-GAAP sales, general and administration costs for fiscal year 2025 are expected to be approximately $32 million to $34 million and non-GAAP sales, general and administration costs for fiscal year 2026 are expected to be approximately $35 million to $37 million.

News

Guidance

BZAI

Blaize Sees FY25 Revenue Guidance Of $19M-$50M; FY26 Revenue Of $105M-$140M; Software Revenue To Rise From 15%-25% In FY25 To 20%-30% In FY26; Non-GAAP R&D Costs At $49M-$52M In FY25, $85M-$89M In FY26; Non-GAAP SG&A Costs At $32M-$34M In FY25, $35M-$37M In FY26

Offerings

MMA.inc  Launches First Ever Fully Integrated Community And Commerce Platform, Unifying Fans, Fighters, Coaches, Gym Owners, And Brands Into A Single, Monetized Ecosystem

Truist Securities analyst Miller Jump reiterates SolarWinds (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SWI#NYSE">SWI</a>) with a Hold and raises the price target from $13 to $18.5.

Price Target

Reiteration

Analyst Ratings

Truist Securities Reiterates Hold on SolarWinds, Raises Price Target to $18.5

Truist Securities analyst Michael Swartz maintains Patrick Industries (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PATK#NASDAQ">PATK</a>) with a Buy and raises the price target from $115 to $120.

PATK

Truist Securities Maintains Buy on Patrick Industries, Raises Price Target to $120

<a href="https://substack.com/@samro"></a>
<figure class="wp-block-image"><a href="https://substackcdn.com/image/fetch/f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fe05803ba-2e47-4fb9-8bb4-48b8179927f8_1320x459.png" target="_blank" rel="noreferrer noopener"><img decoding="async" src="https://substackcdn.com/image/fetch/w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fe05803ba-2e47-4fb9-8bb4-48b8179927f8_1320x459.png" alt="" /></a><figcaption class="wp-element-caption">The S&amp;P 500 is within reach of record highs. (Source:&nbsp;FRED)</figcaption></figure>
&#x1f4c9;The stock market fell last week, with the S&amp;P 500 shedding 0.2% to close at 6,025.99. It's now up 2.5% year to date and up 68.5% from its October 12, 2022 closing low of 3,577.03. 
Despite the looming threat of tariffs, the stock market continues to trade near record highs.
This is a bit confounding since tariffs would be bad for earnings, and earnings are the&nbsp;<a href="https://www.tker.co/i/42137695/earnings-drive-stock-prices">most important driver</a>&nbsp;of stock prices.
Perhaps the market is betting that any tariffs will either be short-lived or less burdensome than feared.
<h2 class="wp-block-heading">Standing by to revise earnings estimates lower &#x1f4c9;</h2>
As we&nbsp;discussed on Monday, the effects of&nbsp;new tariffs&nbsp;on goods imported from Mexico, Canada, and China have not been factored into a lot of companies' earnings guidance.
While the tariffs on Mexico and Canada have been delayed for a month, they very much remain on the table. So&nbsp;<a href="https://www.tker.co/p/wall-street-agrees-tariffs-are-bad">investors should be aware</a>&nbsp;of their potential consequences.
Unfortunately, their consequences go beyond just the direct effects of higher costs on production and higher prices on demand. This makes estimating their full impact on earnings difficult to pinpoint.
"We estimate that every 5pp increase in the U.S. tariff rate would reduce S&amp;P 500 EPS by roughly 1-2%," Goldman's Kostin said. "As a result, if sustained, the tariffs announced [on February 1] would reduce our S&amp;P 500 EPS forecasts by roughly 2-3%, not taking into account any additional impact from major financial conditions tightening or a larger-than-expected effect of policy uncertainty on corporate or consumer behavior."
BofA's Savita Subramanian estimates: "China+Canada+Mexico tariffs could be as much as an 8% hit to EPS."
According to&nbsp;FactSet, analysts estimate S&amp;P 500 EPS will grow 13.0% to $272 in 2025 and 13.8% to $309 in 2026. So the announced tariffs could have a meaningful impact on earnings. And keep in mind that President Trump has discussed imposing tariffs&nbsp;<a href="https://www.tker.co/p/wall-street-agrees-tariffs-are-bad">beyond what's been announced</a>.
&#8220;We estimate that the current tariffs explicitly mentioned could result in an EPS headwind from first order effects of $7.50, $6.10 and $2.60 from Mexico, Canada and China tariffs, respectively," JPMorgan's Dubravko Lakos-Bujas wrote. "If we were to presume that Europe would face a 10% tariff, that would be another $3.60. In short, this could impact up to 2/3 of S&amp;P 500 EPS growth this year from just the currently announced tariffs.&#8221;
<figure class="wp-block-image"><a href="https://substackcdn.com/image/fetch/f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F44fb2ef3-31c1-4cf2-bacb-d010952fd31f_1746x1166.png" target="_blank" rel="noreferrer noopener"><img decoding="async" src="https://substackcdn.com/image/fetch/w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F44fb2ef3-31c1-4cf2-bacb-d010952fd31f_1746x1166.png" alt="" title="" /></a><figcaption class="wp-element-caption">Tariffs are expected to eat into earnings. (Source: JPMorgan)</figcaption></figure>
Even if tariffs ultimately aren't imposed, the uncertainty and volatility caused by the threat of tariffs could prove costly. Among other things, it's already affecting&nbsp;how importers time their purchases, which can come with higher storage costs and increased risk of inventory held or sold at a loss.
<h2 class="wp-block-heading">The good news &#x1f44d;</h2>
For now, earnings continue to perform remarkably well.
Nearly two thirds of the S&amp;P 500 companies have reported Q4 earnings. According to&nbsp;FactSet, EPS growth is on track to grow by 16.4% year-over-year, the highest growth rate since Q4 2021. This is significantly higher than the 11.8% growth expected by analysts at the beginning of the year.
<figure class="wp-block-image"><a href="https://substackcdn.com/image/fetch/f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F39bff2fa-6e2e-468f-80dd-bcd07f07799b_1184x679.png" target="_blank" rel="noreferrer noopener"><img decoding="async" src="https://substackcdn.com/image/fetch/w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F39bff2fa-6e2e-468f-80dd-bcd07f07799b_1184x679.png" alt="" /></a><figcaption class="wp-element-caption">Q4 earnings are coming in much stronger than initially expected. (Source:&nbsp;FactSet)</figcaption></figure>
If this pattern of better-than-expected earnings were to continue — which by the way is one of the&nbsp;<a href="https://www.tker.co/p/earnings-season-q2-24-beat-rates">most consistent trends</a>&nbsp;in stock market history — then it's possible that the downside of any tariffs could be at least partially offset by what would be upside surprises in reported earnings.
Subscribed
<h2 class="wp-block-heading">It's all about earnings &#x1f4b0;</h2>
As I laid out in&nbsp;<a href="https://www.tker.co/i/42137695/earnings-drive-stock-prices">TKer Stock Market Truth No. 5</a>: "News about the economy or policy moves markets to the degree they are expected to impact earnings. Earnings (a.k.a. profits) are why you invest in companies."
As TKer readers&nbsp;understand, earnings are the&nbsp;most important driver of stock prices. Earnings and prices have one of the tightest correlations of any two variables in markets. Just look at the&nbsp;chart below&nbsp;from&nbsp;Goldman Sachs.
<figure class="wp-block-image"><a href="https://substackcdn.com/image/fetch/f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F862aa8ab-389e-489d-8a23-44b311e0e41f_2092x2156.png" target="_blank" rel="noreferrer noopener"><img decoding="async" src="https://substackcdn.com/image/fetch/w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F862aa8ab-389e-489d-8a23-44b311e0e41f_2092x2156.png" alt="" title="" /></a><figcaption class="wp-element-caption">The S&amp;P 500 has tracked earnings over time. (Source:&nbsp;Goldman Sachs)</figcaption></figure>
Goldman Sachs explained: "The close relationship between the economy and market performance is largely driven by earnings. Because corporations are paid in nominal dollars, their sales and earnings tend to track nominal GDP growth over time. Rising sales typically boost profit margins as well, since companies often have some fixed costs that do not scale with higher revenues. As a result, margins historically expanded about two-thirds of the time during past periods with positive sales growth. … Given these linkages, the S&amp;P 500 has closely followed the path of earnings over time. Even with significant expansion in the P/E ratio over the last decade, earnings and dividends still contributed three-fourths of the S&amp;P 500's total return."
That last point is an important one. As much as we all obsess over P/E ratios, the dominant driver of prices has been earnings not valuations. (Indeed, in the&nbsp;<a href="https://www.tker.co/p/pe-ratio-stock-valuation-as-margin-of-error">Feb. 07, 2024 TKer</a>, I said that moves in the P/E ratio just reflect the margin of error in what is a very tight relationship between prices and earnings.)
And by the way, earnings explain&nbsp;why U.S. stocks have smoked non-U.S. stocks.
"The growing dominance of the US equity market has simply mirrored its relative profit growth since the financial crisis," Goldman Sachs' Peter Oppenheimer&nbsp;wrote.
<figure class="wp-block-image"><a href="https://substackcdn.com/image/fetch/f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F3ded482f-c8cf-416e-a900-4f7a54912ad2_2540x1906.png" target="_blank" rel="noreferrer noopener"><img decoding="async" src="https://substackcdn.com/image/fetch/w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F3ded482f-c8cf-416e-a900-4f7a54912ad2_2540x1906.png" alt="" title="" /></a><figcaption class="wp-element-caption">U.S. stocks have outperformed the world because their earnings growth has been better. (Source: Goldman Sachs)</figcaption></figure>
It's worth stating that tariffs also hurt the countries on which tariffs are being imposed.
If the trajectory of earnings were to shift due to tariffs, we should expect prices to follow.
<h2 class="wp-block-heading">Market standoff &#x1f630;</h2>
Because tariffs are almost&nbsp;universally considered negative&nbsp;for all of the economies involved, their implementation would mean&nbsp;<a href="https://www.tker.co/i/156333109/bad-for-inflation-bad-for-economic-growth-bad-for-corporate-profits">earnings estimates will come down</a>.
For now, most&nbsp;companies and analysts&nbsp;appear to be waiting for something firm before they make any revisions.
The stock market, meanwhile, continues to trade near all-time highs. This seems to reflect investors and traders wagering that new tariffs either won't come to fruition or they will be benign.
Maybe the market is right to be trading high, and maybe companies and analysts won't have to cut their earnings estimates. After all, there's a case to be made that&nbsp;<a href="https://www.tker.co/p/stock-market-vigilantes-during-trump-presidency">policymakers don't want to tank the stock market</a>.
In any case: Investing in the stock market would be a whole lot easier if we knew what was to come.

Earnings

Market Summary

Broad U.S. Equity ETFs

Markets

General

For the stock market, it's not bad unless it's bad for earnings

Rivian Automotive Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIVN#NASDAQ">RIVN</a>) launched sales of its Rivian Commercial Van to <a href="https://www.benzinga.com/pressreleases/25/02/b43587285/rivian-opens-sales-of-the-rivian-commercial-van-to-fleets-of-all-sizes-in-the-us">fleet purchasers nationwide</a>.
This electric van serves as the base model for Amazon.com Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) customized delivery vans (EDV). It&#8217;s quipped with automatic emergency braking, collision alerts, and 360-degree visibility.
Amazon, which backs Rivian, agreed in 2019 to buy 100,000 vans <a href="https://www.benzinga.com/tech/25/01/43049866/rivians-electric-vans-to-be-sold-to-non-amazon-customers-from-february-report">from the company by 2030</a>.
The original 2019 agreement restricted Rivian from selling its vans to other companies until four years after the first delivery. By 2023, Rivian modified the deal, removed the exclusivity clause and began selling the vans to other customers.
Also Read: <a href="https://www.benzinga.com/25/01/43419057/rivian-expands-illinois-factory-as-it-gears-to-start-production-of-its-cheaper-r2-suv">Rivian Expands Illinois Factory As It Gears To Start Production Of R2 SUV</a>
After the exclusivity deal with Amazon, Rivian conducted trials of its commercial vans with several major U.S. fleets. These tests have allowed the company to expand sales to a broader market.
Rivian offers the commercial van in two versions, the 500 and 700. The payload capacity reaches 2,663 pounds with a Gross Vehicle Weight Rating (GVWR) of up to 9,500 lbs.
The 500 model boasts a longer range, starting at $83,000. The 700 variant provides more cargo space, with a starting price of $87,000.
&#8220;Amazon currently has more than 20,000 in its fleet and delivered over a billion packages from its Electric Delivery Vans in 2024 alone,&#8221; said Senior Director, Business Development, Tom Solomon.
The vans come with Rivian&#8217;s custom software platform, managing functions such as unlocking, door control, charging, and acceleration. This system enhances the overall user experience by increasing safety, lowering operational expenses, and improving productivity for fleet operators. 
Price Action: Rivian shares are trading higher by 0.88% at $12.59 in premarket at the last check Monday.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/02/43566749/spire-global-lands-72m-contract-for-canadian-wildfire-detection-stock-jumps">Spire Global Lands ~$50M Contract For Canadian Wildfire Detection</a></li>
</ul>
Image: Shutterstock

AMZN

RIVN

Rivian Commercial Van Now Available For Fleets Nationwide In US

The Company Expects Revenue Between $420 Million and $510 Million, Generating &nbsp;a Net Profit Between $16 Million and $20 Million in 2025, Driven by Strategic Initiatives in Supply Chain Financing Solution Services, Small and Medium Enterprise financing solutions, and KFC Franchise Expansion
SHANGHAI, Feb. 10, 2025 /PRNewswire/ -- Nisun International Enterprise Development Group Co., Ltd ("Nisun International" or the "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NISN#NASDAQ">NISN</a>), a technology and industry driven integrated supply chain solutions provider, today provided a comprehensive business forecast for 2025, outlining its strategic initiatives and growth expectations across its core businesses. The Company expects to achieve significant growth in 2025, driven by a combination of operational efficiencies, market expansion, and strategic partnerships.

NISN

Expects Revenue Between $420M-$510M, Generating  A Net Profit Between $16M-$20M In 2025; Expects Its Overall Performance To Increase By 25% To 50% YoY, Driven By The Strong Growth Momentum Across Its Core Businesses

Biotech

BACK

Ignite Proteomics Publishes Study In British Journal of Cancer Titled "Functional activation of the AKT–mTOR signalling axis in a real-world metastatic breast cancer cohort"

Truist Securities analyst Keith Hughes maintains Mohawk Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MHK#NYSE">MHK</a>) with a Buy and lowers the price target from $155 to $148.

Truist Securities Maintains Buy on Mohawk Industries, Lowers Price Target to $148

Many are sounding the alarms over Elon Musk's recent access to the <a href="https://www.benzinga.com/news/legal/25/02/43539572/musk-allies-face-treasury-data-limits-as-judge-steps-in">U.S. Department of Treaury's payment system</a>, which is responsible for handling over $6 trillion in annual federal payments. A large concern is surrounding Musk's access to millions of American's data and payments that directly affect their well-being, like Social Security, Medicare, and other government benefits.&nbsp;
While the Treasury Department insists that no payments have been delayed or altered, advocacy groups and lawmakers are warning of potential risks.&nbsp;
Don't Miss:
<ul>
<li><a href="https://www.benzinga.com/money/gbr-savings-by-age">If You're Age 35, 50, or 60: Here&#8217;s How Much You Should Have Saved Vs. Invested By Now</a></li>
<li>The average American couple has saved this much money for retirement —<a href="http://www.benzinga.com/money/smartasset"> How do you compare</a>?</li>
</ul>
<h2 class="wp-block-heading">Why Changed and Why It Matters</h2>
The recently created Department of Government Efficiency (DOGE), which Musk is leading, was recently granted access to the Treasury Department's payment infrastructure as part of its efforts to minimize waste in government spending. Allowing the access has sparked outroar from lawmakers, advocacy groups, and citizens across the country, with many questioning the legality of such a move and how it could impact critical federal benefits for Americans.&nbsp;
<a href="https://home.treasury.gov/news/press-releases/sb0009">According to a letter</a> sent by the Treasury Department to Congress, DOGE now has "read-only" access, meaning Musk's team shouldn't be able to directly modify or stop payments. However, the concern remains on what his level of access could mean in the long run.&nbsp;
The president and CEO of the National Committee to Preserve Social Security and Medicare, Max Richtman, shared his strong opposition to Musk's access to the payment system. "Social Security beneficiaries and their families have every reason to be alarmed by Elon Musk's takeover of the U.S. Department of Treasury's payment system…Seniors, their families, and people with disabilities most certainly cannot trust Trump and Musk with their crucial federal benefits — or their personal data," he <a href="https://www.ncpssm.org/documents/latest-news/social-security-beneficiaries-cant-trust-musk-with-payments-personal-data/">said on the organization's website</a>.&nbsp;
Trending: Nancy Pelosi Invested $5 Million In An AI Company Last Year — <a href="https://www.benzinga.com/money/elf-labs-nancy-pelosi">Here's How You Can Invest In Multiple Pre-IPO AI Startups With Just $1,000</a>
<h2 class="wp-block-heading">Lawmakers Raise Red Flags</h2>
Democratic lawmakers have expressed serious concern about DOGE's authority. U.S. Sen <a href="https://www.benzinga.com/news/25/02/43474551/elon-musk-says-elizabeth-warren-is-meddling-with-trillions-in-us-treasury-via-unqualified-flunkies">Elizabeth Warren</a> of Massachuseetts <a href="https://x.com/ewarren/status/1886505257649242388">took to X</a> to raise her concerns about the move, calling it "extraordinarily dangerous."&nbsp; She noted that millions of Americans depend on uninterrupted payments from the government for their financial well-being.&nbsp;
Lindsay Owens, executive director of Groundwork Collaborative, <a href="https://www.cnbc.com/2025/02/05/how-musks-access-to-treasury-system-may-impact-social-security.html">spoke with CNBC</a> and described the takeover as a "five-alarm fire," stating that as a private citizen with no official government role, Musk was given access to this sensitive system. The White House has said Musk is a <a href="https://www.justice.gov/jmd/ethics/summary-government-ethics-rules-special-government-employees">special government employee</a>.&nbsp;
Complicating the issue further, <a href="https://edition.cnn.com/2025/02/06/politics/elon-musk-treasury-department-payment-system/index.html">CNN reported</a> that Musk's associates at DOGE have attempted to influence federal payments. The network obtained emails showing top DOGE officials attempting to block U.S. Agency for International Development spending, just days after President Donald Trump's inauguration last month. This leaves government officials and citizens alike questioning whether similar moves may occur with <a href="https://www.benzinga.com/personal-finance/25/02/43464483/protect-billionaires-bottom-lines-dnc-criticizes-trumps-social-security-agenda">Social Security</a> and other domestic programs.&nbsp;
Trending: Many are using retirement income calculators to check if they&#8217;re on pace —<a href="https://www.benzinga.com/money/how-do-i-calculate-my-retirement-income-adv"> here&#8217;s a breakdown on what&#8217;s behind this formula.</a>
<h2 class="wp-block-heading">The Treasury Department's Response</h2>
Despite the concerns, the Treasury Department issued a letter to Congress stating that Social Security and Medicare payments have been processed as usual. A White House official stated that DOGE is only looking to restructure the payment system according to the President's goals and executive order, which currently don't include any disruption to Social Security.&nbsp;
However, <a href="https://www.benzinga.com/news/legal/25/02/43542558/trumps-push-to-reshape-federal-workforce-stalls-in-court">federal worker buyouts</a> under the Trump administration could indirectly impact Social Security, according to U.S. Sen. Kirsten Gillibrand (D-NY). "Trump's buyout offer would have devastating consequences for the tens of millions of Americans who rely on Social Security,"&nbsp; <a href="https://www.gillibrand.senate.gov/news/press/release/gillibrand-slams-trump-policy-that-would-gut-social-security-administration-make-it-harder-for-seniors-to-receive-benefits/">she said</a>.
The administration has offered early retirement incentives to federal employees, leading to concerns that staff shortages could slow down Social Security claims processing. The agency already faces long wait times, with average phone support delays reaching 45 minutes and disability benefit determinations taking up to 230 days.
See Also: <a href="https://www.benzinga.com/money/elon-musk-told-the-u-n-if-they-could-show-a-plan-for-ending-world-hunger-hed-donate-6-billion-i-will-sell-tesla-stock-right-now-and-do-it">Elon Musk Told The U.N. If They Could Show A Plan For Ending World Hunger He'd Donate $6 Billion – ‘I Will Sell Tesla Stock Right Now And Do It'</a>
<h2 class="wp-block-heading">What This Means for Social Security Recipients</h2>
For now, <a href="https://www.benzinga.com/personal-finance/25/01/42920272/despite-a-modest-50-monthly-increase-in-2025-americans-worry-social-security-may-not-survive-past-2034">Social Security beneficiaries</a> continue to receive their payments as scheduled. But watchdog organizations and lawmakers will be closely monitoring DOGE's role in federal payment processing. Advocacy groups have called for legal action to prevent any potential interference with Social Security benefits, and pending lawsuits may determine the future scope of DOGE's authority over federal funds.
While no immediate disruptions have been reported, the uncertainty surrounding Musk's access to Treasury operations leaves many retirees and beneficiaries on edge. As discussions continue in Washington, Social Security recipients are advised to stay informed and reach out to their representatives to voice their concerns.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/money/mark-cubans-advice-for-lotto-winners">Many are surprised by Mark Cuban's advice for lotto winners: Cash or annuity?</a></li>
<li>Can you guess how many retire with a $5,000,000 nest egg? <a href="https://www.benzinga.com/money/5mil-nest-egg-adv">The percentage may shock you</a>.</li>
</ul>

Personal Finance

'Social Security Beneficiaries Have Every Reason To Be Alarmed' By Musk's Access To U.S. Department Of Treasury Payment System

On Monday, TC BioPharm (Holdings) PLC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCBP#NASDAQ">TCBP</a>) announced the first Cohort B patient in the ACHIEVE Phase 2B UK trial of TCB008 in Acute Myeloid Leukemia has completed the full dosing regimen.
The ACHIEVE trial is an open-label Phase 2 study evaluating the efficacy and safety of TCB008.
The trial is focused on assessing TCB008&#8217;s effectiveness and tolerability in patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS/AML) with refractory or relapsed conditions.
Also Read: <a target="_blank" href="https://www.benzinga.com/general/biotech/24/12/42551325/exclusive-penny-stock-tc-biopharm-proposes-special-stock-dividend" rel="noreferrer noopener">EXCLUSIVE: Penny Stock TC BioPharm Proposes Special Stock Dividend</a>
Cohort B recruits patients who have achieved remission following previous treatment yet continue to have a detectable or minimal residual disease (MRD).
Recruitment into Cohort B was initiated during the fourth quarter of 2024, ahead of the company&#8217;s anticipated schedule.
The first Cohort B patient received their dose in October 2024.
The initial Cohort B patient has completed the dosing regimen, received all four planned doses of TCB008, and is expected to receive an additional fifth dose.
Enrolment of a second Cohort B patient has also been initiated.
The trial&#8217;s safety objectives and endpoints evaluate patient responses to TCB008, including grading of adverse events experienced and the incidence and severity of cytokine release syndrome and neurotoxicity.
A review of preliminary data shows no drug-related adverse events following cumulative infusions of TCB008, containing <a target="_blank" href="https://www.benzinga.com/pressreleases/24/12/n42615458/tcbp-advances-achieve-phase-2b-clinical-trial-with-final-dosing-of-3-patients" rel="noreferrer noopener">up to a billion cells</a>.
&#8220;We expect to complete enrolment in the second cohort in the first half of 2025, with data readout anticipated later this year,&#8221; said&nbsp;&lt; Bryan Kobel, TC BioPharm&#8217;s CEO.
In December, TC BioPharm announced it advanced negotiations with both of its previously aforementioned acquisition candidates.
Earlier, TCBP announced the execution of non-binding letters of intent as part of its M&amp;A strategy to expand its therapeutic platform. The company continues to pursue its expansion strategy via acquisition, specifically in new indications and new <a target="_blank" href="https://www.benzinga.com/pressreleases/24/12/n42742389/tcbp-provides-update-on-acquisition-strategy-and-current-targets" rel="noreferrer noopener">cell therapy modalities</a>.
Price Action: TCBP stock closed at $0.20 on Friday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/02/43570917/cloudflares-ai-expansion-and-enterprise-growth-set-the-stage-for-big-gains-analysts" target="_blank" rel="noreferrer noopener">Buy Cloudflare Or Sell? Analysts Vary Over Sales Acceleration And Business Momentum</a></li>
</ul>

Health Care

Exclusives

TCBP

EXCLUSIVE: Nano-Cap TC BioPharm Concludes Initial Cohort B Patient Dosing In Mid-Stage Leukemia Trial, Data Readout By End Of 2025

Global Payments (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GPN#NYSE">GPN</a>) has outperformed the market over the past 20 years by 2.28% on an annualized basis producing an average annual return of 10.65%. Currently, Global Payments has a market capitalization of $27.89 billion. 
Buying $100 In GPN: If an investor had bought $100 of GPN stock 20 years ago, it would be worth $757.82 today based on a price of $109.60 for GPN at the time of writing.
<h3>Global Payments's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1739196911_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

$100 Invested In Global Payments 20 Years Ago Would Be Worth This Much Today

Market-Moving Exclusives

EXCLUSIVE: TC BioPharm Tells Benzinga Co. Announces Successful Completion Of Initial Cohort B Patient Dosing In The ACHIEVE Clinical Trial

Contracts

AVAV

AeroVironment Subsidiary Arcturus UAV Awarded $181M Contract From Danish Defence For 10-Year JUMP 20 Aircraft System Program To Enhance ISR Operations

Guggenheim analyst Debjit Chattopadhyay reiterates Rezolute (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RZLT#NASDAQ">RZLT</a>) from Buy to Buy.

RZLT

Guggenheim Reiterates Buy on Rezoluteto Buy

Truist Securities analyst Peter Osterland maintains Minerals Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTX#NYSE">MTX</a>) with a Buy and lowers the price target from $103 to $101.

Truist Securities Maintains Buy on Minerals Technologies, Lowers Price Target to $101

On Monday, Boeing Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) stated that it would require a significant increase in orders from India before establishing a final civil aircraft assembly line in the country.
&#8220;The business case for final assembly in any region must be far larger than what the Indian market currently supports,&#8221; said Salil Gupte, president of Boeing India and South Asia, in an interview with <a href="https://www.reuters.com/business/aerospace-defense/boeing-signals-more-orders-needed-before-setting-up-assembly-line-india-2025-02-10/" target="_blank" rel="noreferrer noopener">Reuters</a>. &#8220;It requires many more airplanes than are being bought in India today.&#8221;
Gupte emphasized a step-by-step approach to expanding final assembly in India, highlighting the need for market growth in the region.
Indian airlines, including Air India and IndiGo, have around 1,800 aircraft on order from global manufacturers with 130 jets set for delivery this year, according to Cirium Ascend.
Also Read: <a target="_blank" href="https://www.benzinga.com/trading-ideas/movers/25/02/43581856/us-greenlights-7-4-billion-military-deal-with-israel-key-weapons-deals-explained" rel="noreferrer noopener">US Greenlights $7.4 Billion Military Deal With Israel: Key Weapons Deals Explained</a>.
Last week, Boeing <a target="_blank" href="https://boeing.mediaroom.com/news-releases-statements?item=131523" rel="noreferrer noopener">projected that India and South Asia&#8217;s commercial airplane fleet</a> will nearly quadruple over the next 20 years, driven by more than 7% annual air traffic growth through 2043. This expansion will be fueled by economic growth, improved connectivity, and supportive air travel policies.
The forecast also highlights rising demand for fuel-efficient aircraft, with nearly 90% of deliveries expected to be single-aisle jets like the 737 MAX. Widebody fleets will expand as airlines develop long-haul routes, while cargo freighter fleets are set to grow five-fold. Additionally, the region will see the world&#8217;s fastest-growing demand for aviation professionals, with pilot, cabin crew and technician needs projected to quadruple to 129,000.
Price Action: At the last check on Monday, BA shares were trading higher by 0.47% at $182.35 premarket.
Photo: Shutterstock

Boeing Seeks More Orders Before Committing To Indian Aircraft Assembly Line

Guggenheim analyst Debjit Chattopadhyay reiterates Centessa Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNTA#NASDAQ">CNTA</a>) from Buy to Buy.

CNTA

Guggenheim Reiterates Buy on Centessa Pharmaceuticalsto Buy

Truist Securities analyst Michael Swartz maintains LCI Indus (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LCII#NYSE">LCII</a>) with a Hold and raises the price target from $102 to $108.

LCII

Truist Securities Maintains Hold on LCI Indus, Raises Price Target to $108

SNCY

CORRECTION: Reported Earlier, Sun Country Airlines Prices Secondary Public Offering Of 6,346,105 Shares Of Its Common Stock By An Affiliate Of Certain Investment Funds Managed By Affiliates Of Apollo Global Management

Comments

Minor International

Minor International (MIPCF) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga